HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) 083881.Supplemental Data All Versions of this Article: clinchem.2006.083881v1 53/5/845    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Zee, R. Y.L. Articles by Ridker, P. M Search for Related Content PubMed PubMed Citation Articles by Zee, R. Y.L. Articles by Ridker, P. M Related Collections Molecular Diagnostics and Genetics Nutrition Lipids, Lipoproteins, and Cardiovascular Risk Factors Endocrinology and Metabolism

Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women

¹ Donald W. Reynolds Center for Cardiovascular Research,² Leducq Center for Molecular and Genetic Epidemiology, and³ Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and⁴ Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, and⁵ Department of Laboratory Medicine, Children’s Hospital, Harvard Medical School, Boston, MA.
⁶ Department of Human Genetics, Roche Molecular Systems, Inc., Alameda, CA.
⁷ Roche Center for Medical Genomics, Basel, Switzerland.
⁸ Department of Epidemiology, Harvard School of Public Health, Boston, MA.

^aAddress correspondence to this author at: Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Ave. East, Boston, MA 02215. Fax 617-783-9212; e-mail: rzee{at}rics.bwh.harvard.edu.

Background: Hyperhomocysteinemia has been associated with a higher risk of cardiovascular disease (CVD) in epidemiological studies, but recent trials have failed to show a benefit of lowering homocysteine. To address this apparent paradox, we explored whether interaction between genetic and dietary factors related to homocysteine metabolism contributes to CVD risk.

Methods: We evaluated the associations of homocysteine, methylenetetrahydrofolate reductase (MTHFR) 677C>T genotype, and dietary intake of folate/B-vitamins with subsequent CVD events in 24 968 apparently healthy white American women followed for 10 years. Plasma homocysteine was measured using an enzymatic assay. MTHFR genotype was determined with a multiplex PCR using biotinylated primers.

Results: In unadjusted analyses, homocysteine showed moderately strong linear associations with CVD, with hazard ratios (95% CI) comparing top with bottom quintiles for total CVD of 1.92 (1.55–2.37), myocardial infarction 2.32 (1.52–3.54), and ischemic stroke 2.25 (1.45–3.50), all P_trend <0.001. These ratios were markedly attenuated after adjusting for traditional risk factors and socioeconomic status to 1.08 (0.86–1.36), P_trend = 0.12; 1.20 (0.76–1.87), P_trend = 0.14; and 1.21 (0.75–1.94), P_trend = 0.50, respectively. Homocysteine was associated with MTHFR genotype (1.4 µmol/L higher homocysteine for TT vs CC, P <0.001) and inversely with intake of folate, vitamin B₂, B₆, and B₁₂, all P_trend <0.001. However, there was no association of MTHFR genotype or dietary folate/B-vitamins with CVD. In addition, there were no gene–diet or gene–homocysteine interactions in relation to CVD.

Conclusions: In this large-scale prospective study, the association of homocysteine with CVD was markedly attenuated after adjusting for risk factors and was not modified by MTHFR 677C>T or intake of folate or B-vitamins.

The following articles in journals at HighWire Press have cited this article:

				S. D. Barker, S. Bale, J. Booker, A. Buller, S. Das, K. Friedman, A. K. Godwin, W. W. Grody, E. Highsmith, J. A. Kant, et al. Development and Characterization of Reference Materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 Genetic Testing J. Mol. Diagn., November 1, 2009; 11(6): 553 - 561. [Abstract] [Full Text] [PDF]

				G. Pare, D. I. Chasman, A. N. Parker, R. R.Y. Zee, A. Malarstig, U. Seedorf, R. Collins, H. Watkins, A. Hamsten, J. P. Miletich, et al. Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women's Genome Health Study Circ Cardiovasc Genet, April 1, 2009; 2(2): 142 - 150. [Abstract] [Full Text] [PDF]

				M. Ebbing, O. Bleie, P. M. Ueland, J. E. Nordrehaug, D. W. Nilsen, S. E. Vollset, H. Refsum, E. K. Ringdal Pedersen, and O. Nygard Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial JAMA, August 20, 2008; 300(7): 795 - 804. [Abstract] [Full Text] [PDF]

				M. Schurks, R. Y.L. Zee, J. E. Buring, and T. Kurth Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease Neurology, August 12, 2008; 71(7): 505 - 513. [Abstract] [Full Text] [PDF]

				R. Ritch Exfoliation Syndrome: Beyond Glaucoma Arch Ophthalmol, June 1, 2008; 126(6): 859 - 861. [Full Text] [PDF]

				P. M Ridker, D. I. Chasman, R. Y.L. Zee, A. Parker, L. Rose, N. R. Cook, J. E Buring, and for the Women's Genome Health Study Working Group Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women Clin. Chem., February 1, 2008; 54(2): 249 - 255. [Abstract] [Full Text] [PDF]